Primary Malignant Liver Neoplasm — Trials

Primary Malignant Liver Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

3,486 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 807
Recruiting: 471
Ph III recruiting: 42
Growth YoY: +1.5%
Industry share: 21%
Top sponsor: Sun Yat-sen University
Termination share: 34.3%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (402)

clinicaltrialsPublishedShowing 101–150 of 1,275 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT07179900	Radiotherapy Combined With QL1706 and Bevacizumab for Unresectable Non-metastatic Hepatocellular Carcinoma	recruiting	Phase 2	60	Hebei Medical University Fourth HospitalOTHER	1	Aug 3, 2026	clinicaltrials
NCT04912765	Neoantigen Dendritic Cell Vaccine and Nivolumab in HCC and Liver Metastases From CRC	recruiting	Phase 2	60	National Cancer Centre, SingaporeOTHER	1	Jul 31, 2026	clinicaltrials